How Long Can I Live With Kidney Disease?

Cardio Renal Foundation is a 501(c)(3) tax-exempt charity organization. Your donation advances our mission to provide a solution beyond dialysis.

The Honest Short Answer

You have probably already typed this question into a search box at an hour when nobody was awake to ask, so here is the straightest answer research can give: it varies — widely — and for a great many people, kidney disease is not the thing that shortens their life. Most people diagnosed in the early and middle stages will live for many years, and most will eventually die with kidney disease rather than of it — of a heart problem, most often, or of something unrelated entirely. The stage you are in matters. Your age matters. And several things genuinely within reach — blood pressure, blood sugar, protein leaking into the urine, the state of your heart — move the outlook more than the diagnosis itself does. What follows is what the large studies actually found, in plain words, including the numbers. They are averages from other people's lives, not a sentence passed on yours, and the last sections explain why the difference between those two things is not a technicality.

What the Big Registries Found

The clearest numbers come from Alberta, Canada, where researchers used a province-wide laboratory registry — real blood tests from real clinics — to calculate how long people lived at each level of kidney function. Their study was published in the journal Nephrology Dialysis Transplantation in 2012, and its figures are still the ones doctors cite. Kidney function is measured as eGFR, the filtering number explained in our guide to what creatinine is; a healthy young kidney filters at 90 or above, stage 3 runs from 59 down to 30, and stage 4 from 29 down to 15. For a person aged 65, the Alberta researchers found average remaining life ran like this: with filtering at 60 or above, about 12 more years for a man and about 15 for a woman. In stage 3a (filtering 45–59), about 11 years for a man and 13 for a woman — barely less. In stage 3b (filtering 30–44), about 7 years for a man and 9 for a woman. At stage 4 levels (filtering 15–29), about 5 years for either. At 70 the same staircase held, a few years shorter at every step. Two honest cautions belong on top of those numbers. First, they describe groups of thousands; inside every group were people who lived half that long and people who lived twice it, and the average cannot say which kind of outlier you will be. Second, the Alberta group had their blood drawn for real medical reasons, so even its "healthy kidneys" comparison group was not a picture of perfect health — these are clinic-population averages, not the outer limit of what a careful person can expect. Read them as a map of how much the stage matters, not as a date.

The Heart Is the Main Story

Here is the finding that surprises nearly everyone, and it comes from the largest study of its kind: more than 1.1 million adults, published in the New England Journal of Medicine in 2004. As filtering fell below 60, the risk of death climbed in a steady staircase — about 1.2 times the baseline at stage 3a levels, about 1.8 times at stage 3b, about 3.2 times at stage 4, and higher still below that. The risk of a heart attack, heart failure, or another cardiovascular event climbed the same staircase beside it. In other words, the danger kidney disease carries is mostly not that the kidneys stop — it is what struggling kidneys do to the heart and blood vessels along the way: the pressure they raise, the fluid they keep, the strain they add year after year. The National Kidney Foundation makes the same point in plain language: people with kidney disease are more likely to die of heart disease than to reach kidney failure. That is not a reason for despair. It is the reason this site treats the heart and the kidneys as one story, and it is why the next section matters more than the numbers do.

Why One Number Will Never Fit You

Filtering is only half your kidney report. The other half is albumin — protein leaking into the urine, the subject of our article on why urine turns foamy — and the same Alberta team showed it can matter as much as the filter number itself. In a 2014 follow-up study, they looked at 50-year-olds whose filtering was still 60 or above and split them by protein: men with no protein in the urine averaged about 25 more years of life; men with heavy protein averaged about 13 — a difference of more than 11 years at the same filtering level. For women the gap was wider still, about 29 years against about 15. Two people can share a stage, share an age, and face genuinely different outlooks because one kidney leaks protein and the other does not, because one person's numbers have sat still for five years while the other's slide a little every year, because one carries diabetes and the other does not. This is also why internet averages — including the ones on this page — can only frame the question. The answer with your name on it is built from your stage, your protein number, your trend, and your heart, and only a clinician holding all four can read it properly.

What Actually Moves the Number

The studies agree on the levers, and none of them is exotic. Blood pressure is the first: it is both a cause of kidney damage and its accelerant, and keeping it in the range your doctor sets is the single most proven way to slow the slide. Blood sugar is the second — diabetes is the leading cause of kidney disease, and its control protects the filter that remains. Protein in the urine is the third; modern kidney care includes medicines specifically prescribed because they reduce that leak and protect both kidney and heart, which is why a prescription you were given "for blood pressure" may be doing double duty. Smoking belongs on the list without decoration — it speeds the disease and multiplies the heart risk that does most of the killing. So does care with everyday painkillers of the ibuprofen family, which healthy kidneys shrug off and struggling kidneys cannot; that is a conversation to have before the next sore knee, not after. And underneath all of it sits the trend: a filtering number checked on schedule, so that a slide is caught in a season rather than discovered in a crisis. There is one more thing worth saying about every number on this page: they describe the past — the outcomes of people treated with the medicine of their time. The Cardio Renal Foundation supports research toward a solution beyond dialysis, work designed to find treatments that could one day change the outlook these studies describe. That is a direction, not a promise; nothing in a laboratory can be prescribed today. But averages are not laws, and they have moved before.

Questions Worth Asking Your Own Doctor

Bring the averages home by trading them for your own figures. Ask: What is my eGFR, and what has it done over the last several checks — falling, steady, or noisy? How much protein is in my urine, and what are we doing about it? Is my blood pressure where you want it, at home as well as in this office? What is my heart's share of this picture, and has it been looked at directly? Which of my medicines protect the kidneys, and which need watching? If you have been given a stage, the stage pages on this site go deeper: our article on how long you can live with stage 3 kidney disease takes that stage apart, the stage 4 companion does the same for the harder country, and if treatment is already part of your life, how long you can live on dialysis answers that question with the same honesty. The map of all five stages sits in the 5 stages of chronic kidney disease.

At the Cardio Renal Foundation, we publish education for exactly this reader — the one who got a number, went home, and asked the internet the question she could not ask out loud. The honest answer is that the number is the beginning of the story, not its end. Support from readers like you helps us keep publishing it.

This article is informational only and is not meant to replace the advice of your qualified healthcare provider. Every life-expectancy figure here is a population average from the published studies named in the text — the 2012 Alberta registry study in Nephrology Dialysis Transplantation, its 2014 albuminuria follow-up, and the 2004 New England Journal of Medicine cohort — and none of them is a prediction about any individual reader. Your own outlook depends on your stage, your protein level, your other conditions, and your care, and only your own clinician can weigh them. Nothing here diagnoses any condition or recommends any treatment, and research supported by this Foundation is investigational only — it is not a therapy available today. If you develop chest pain or pressure, severe breathlessness, or another symptom that feels like an emergency, call 911 immediately. As with any issues related to your health, check with your doctor.